What’s new in psoriasis? Analysis of the clinical significance of new guidelines and systematic reviews on psoriasis published in 2008 and 2009

This review summarizes the clinical importance of 18 systematic reviews and guidelines on psoriasis published or indexed between November 2008 and October 2009. The topics covered include guidance on the use of topical, systemic and biological therapies for the treatment of psoriasis; comorbidities associated with psoriasis; and complementary therapies for psoriasis. A similar and more detailed review to this appeared in the 2009 Annual Evidence Update on Psoriasis from NHS Evidence – Skin Disorders in November 2009.

[1]  Justin Bailey,et al.  Topical treatments for chronic plaque psoriasis. , 2010, American family physician.

[2]  J. Gelfand,et al.  Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature. , 2009, Journal of the American Academy of Dermatology.

[3]  S. Papanicolaou,et al.  PSY12 ECONOMIC AND CLINICAL EFFICACY BENEFITS OF THE USE OF USTEKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN GREECE , 2009 .

[4]  L. Naldi,et al.  European S3‐Guidelines on the systemic treatment of psoriasis vulgaris , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  R. Balkrishnan,et al.  Using ‘number needed to treat’ to help conceptualize the magnitude of benefit and risk of tumour necrosis factor‐α inhibitors for patients with severe psoriasis , 2009, The British journal of dermatology.

[6]  Courtney I. Jarvis,et al.  Ustekinumab: Treatment of Adult Moderate-to-Severe Chronic Plaque Psoriasis , 2009, The Annals of pharmacotherapy.

[7]  P. Sfikakis,et al.  Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. , 2009, Journal of the American Academy of Dermatology.

[8]  A. Gottlieb,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. , 2009, Journal of the American Academy of Dermatology.

[9]  M. Falagas,et al.  The therapeutic effect of balneotherapy: evaluation of the evidence from randomised controlled trials , 2009, International journal of clinical practice.

[10]  J. Schmitt,et al.  Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Targeted Treatment of Psoriasis with Adalimumab: a Critical Appraisal Based on a Systematic Review of the Literature , 2022 .

[11]  M. Lebwohl,et al.  Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation. , 2009, Journal of the American Academy of Dermatology.

[12]  E. Loveman,et al.  Infliximab for the treatment of adults with psoriasis. , 2009, Health Technology Assessment.

[13]  G. Fiorino,et al.  Review article: anti TNF‐α induced psoriasis in patients with inflammatory bowel disease , 2009, Alimentary pharmacology & therapeutics.

[14]  A. Gottlieb,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. , 2009, Journal of the American Academy of Dermatology.

[15]  S. Prey,et al.  Effect of folic or folinic acid supplementation on methotrexate‐associated safety and efficacy in inflammatory disease: a systematic review , 2009, The British journal of dermatology.

[16]  A. Gottlieb,et al.  Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases , 2009, The Journal of dermatological treatment.

[17]  M. Lebwohl,et al.  Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation. , 2009, Journal of the American Academy of Dermatology.

[18]  R. Willemsen,et al.  Alexithymia and dermatology: the state of the art , 2008, International journal of dermatology.

[19]  J. S. Henning,et al.  Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. , 2008, Arthritis and rheumatism.

[20]  C. Griffiths,et al.  Pathogenesis and clinical features of psoriasis , 2007, The Lancet.